Exosome Scaffold Engineering Service via Lamp2b & CD63 for CAR-T Cytokine

Online Inquiry

Background Service What We Can Offer Workflow Highlights FAQs Contact

Current CAR-T therapies face significant hurdles including limited in vivo persistence, severe systemic cytokine toxicity, and a suppressive tumor microenvironment that blunts antitumor efficacy. Creative Biolabs' Exosome Scaffold Engineering service leverages Lamp2b and CD63 fusion platforms to engineer exosomes for precise, stable display of immunomodulatory cytokines. We design and produce custom exosomes capable of delivering these therapeutic payloads directly to the CAR-T cell synapse, enabling targeted autocrine stimulation. This approach enhances CAR-T functionality and persistence at the tumor site while minimizing off-target toxicity, providing you with a powerful tool to develop safer and more potent next-generation immunotherapies.

Introduction

Exosome scaffold engineering represents a cutting-edge strategy to reprogram extracellular vesicles as targeted delivery platforms, enabling the precise packaging and presentation of therapeutic cytokines for enhanced CAR-T immunotherapy. Leveraging Lamp2b as a modular scaffold facilitates the efficient surface display of targeting ligands, while CD63 serves as a versatile platform for incorporating functional domains, collectively optimizing payload stability, circulation half-life, and biological activity.

Fig.1 CAR-T cytokine delivery via lamp2b & CD63-engineered exosome scaffolds. (Creative Biolabs Original) Fig.1 Lamp2b & CD63-based exosome scaffolding for CAR-T cytokine applications.

Our Service

Creative Biolabs provides a turnkey solution for the design and production of engineered extracellular vesicles (EVs) tailored for CAR-T support. We specialize in the genetic fusion of therapeutic cytokines to the N-terminus of Lamp2b or the extracellular loops of CD63. This ensures that your therapeutic proteins are not just "near" the exosome but are structurally integrated and oriented for maximum receptor interaction.

What We Can Offer

We offer a comprehensive suite of exosome scaffold engineering platforms designed to enhance CAR-T cell therapy. Our technologies enable precise surface functionalization, advanced modulation of cellular targeting, and versatile non-genetic modifications for optimized immunotherapeutic applications.

Featured services of precision CAR-protein enrichment & exosomal sorting technology at Creative Biolabs. (Creative Biolabs Original)

Our Service Process

Required Starting Materials:

To commence the service, you need to supply the target cytokine's coding sequence and chosen parental cell line.

Key Steps:

Workflow of precision CAR-protein enrichment & exosomal sorting technology at Creative Biolabs. (Creative Biolabs Original)

Final Deliverables: Deliverables include purified, engineered exosomes, comprehensive characterization data, and the stable producer cell line to support ongoing production.

Key Advantages

Precision Targeting Capability: By fusing targeting moieties to the N-terminus of Lamp2b, engineered exosomes can be directed to specifically bind to tumor cells or the tumor microenvironment, significantly enhancing therapeutic precision.
Enhanced Functional Payload Display: Leveraging the structural characteristics of CD63 allows for the insertion of larger functional domains into its extracellular loops, enabling the exosome to simultaneously carry and present multiple therapeutic molecules.
Extended In vivo Half-Life: The display of albumin-binding domains via either Lamp2b or CD63 allows exosomes to hitchhike on circulating albumin, dramatically prolonging their systemic circulation time and improving drug accumulation at target sites.

FAQs

Q1: Can multiple cytokines be displayed simultaneously on a single exosome?

A1: Our multiplex platform supports concurrent expression of distinct scaffold fusions, such as Lamp2b-IL-7 alongside CD63-IL-15, enabling combinatorial immune modulation from individual vesicles.

Q2: How is proper cytokine conformation and bioactivity maintained post-fusion?

A2: Incorporation of flexible linker sequences preserves native protein folding and receptor accessibility, eliminating steric constraints that could compromise functionality.

Q3: What distinguishes CD63 from Lamp2b as a display scaffold?

A3: CD63 features multiple extracellular loop domains ideal for presenting smaller peptide-based immunomodulators, whereas Lamp2b accommodates larger globular cytokine payloads with higher efficiency.

Why Choose Us

We specialize in precision exosome engineering using Lamp2b and CD63 scaffolds for targeted cytokine delivery to CAR-T cells. Our proprietary technology ensures selective cargo enrichment and enhanced in vivo stability, empowering next-generation immunotherapies with improved efficacy and safety.

Customer Reviews

"The CD63 scaffold service markedly enhanced memory T-cell subset expansion in our CAR-T studies, demonstrating superior efficacy compared to recombinant protein counterparts." Dr. Al***rt S.

"Lamp2b-engineered exosomes achieved superior bone marrow biodistribution with remarkable specificity, a targeting outcome unattainable with conventional viral vectors." Prof. M***na K.

"Utilizing this localized exosome delivery system substantially reduced off-target cytokine release syndrome manifestations in vivo, confirming that targeted delivery mitigates systemic toxicity." Dr. J***n H.

How to contact us?

Unlock the full potential of your CAR-T program with our Lamp2b/CD63 exosome scaffold engineering. Achieve superior cytokine delivery with enhanced precision and half-life. For inquiries regarding collaboration or project discussions, please contact our expert team today.

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.